Knight Therapeutics (TSX:GUD) Change In Inventory : C$0.7 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Change In Inventory?

Knight Therapeutics's change in inventory for the quarter that ended in Dec. 2023 was C$18.4 Mil. It means Knight Therapeutics's inventory declined by C$18.4 Mil from Sep. 2023 to Dec. 2023 .

Knight Therapeutics's change in inventory for the fiscal year that ended in Dec. 2023 was C$0.7 Mil. It means Knight Therapeutics's inventory declined by C$0.7 Mil from Dec. 2022 to Dec. 2023 .

Knight Therapeutics's Total Inventories for the quarter that ended in Dec. 2023 was C$91.8 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Knight Therapeutics's Days Inventory for the quarter that ended in Dec. 2023 was 233.11.

Inventory Turnover measures how fast the company turns over its inventory within a year. Knight Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.39.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Knight Therapeutics's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.38.

Knight Therapeutics Change In Inventory Historical Data

The historical data trend for Knight Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Change In Inventory Chart

Knight Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

8.15

9.71

-17.19

-11.43

0.70

Knight Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-9.43	-2.63	-2.07	-12.96	18.35

Knight Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.7 Mil.

Knight Therapeutics (TSX:GUD) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Knight Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	102.1405	/	39.982	*	365 / 4
	=	233.11

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Knight Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	39.982	/	102.1405
	=	0.39

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Knight Therapeutics's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	102.1405	/	74.197
	=	1.38

Knight Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Knight Therapeutics (TSX:GUD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (TSX:GUD) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

KHTRF:USA

Address

3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8

Website

https://www.gud-knight.com

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Executives

Sime Armoyan

10% Security Holder

Knight Therapeutics (TSX:GUD) Headlines

No Headlines